While melanoma is relatively rare, accounting for only 1% of all skin cancer cases, rates of melanoma have been rising rapidly over the past few decades. It is responsible for the majority of skin cancer deaths, according to the American Cancer Society.
2025
Evaxion concludes subject dosing in Phase II trial of melanoma vaccine
Evaxion Biotech has completed subject dosing in the Phase II trial of its personalised peptide-based cancer vaccine, EVX-01, for the treatment of advanced melanoma, also referred to as skin cancer.
More Women And Young People Are Getting Cancer Than Before, New Report Shows
The cancer burden in the United States is shifting towards women and younger people, a new American Cancer Society study released Thursday shows, with disease rates in one group—women aged 50 to 64—surpassing those of men for the first time.
Research spotlight: Improving predictions about brain cancer outcomes with the right imaging criteria
Raymond Y. Huang, MD, Ph.D., of the Department of Radiology at Brigham and Women’s Hospital, is the corresponding author of a paper published in the Journal of Clinical Oncology, “Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204.”